Headquarters
3724 THOMAS POINT RD, ANNAPOLIS, MD 21403-5009, US
ANNAPOLIS, MD, US
ALPHYN BIOLOGICS, INC.
From the company
Alphyn Biologics is a clinical-stage dermatology life science company developing first-in-class Multi-Target Therapeutics (MTT) for severe and prevalent skin diseases based on its Zabalafin Platform (AB-101 Platform). Its lead product candidate, zabalafin hydrogel (AB-101a), is in development for mild-to-moderate atopic dermatitis and has completed a Phase 2a clinical trial. The company became operational in March 2020 and is based in Annapolis, Maryland and Cincinnati, Ohio, with an Australian subsidiary and a European presence in Vienna, Austria.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.